INTERNATIONAL PATENT: ELPISCIENCE (SUZHOU) BIOPHARMA, LTD., ELPISCIENCE BIOPHARMA, LTD. FILES APPLICATION FOR "ANTI-NKG2A ANTIBODIES, FUSION PROTEINS AND USES THEREOF"

GENEVA, Jan. 4 -- ELPISCIENCE (SUZHOU) BIOPHARMA, LTD. (Unit E729, Floor 5, Lecheng Plaza, Phase II of Biopharmaceutical Industrial Park218 Sangtian St., SIP, China (Jiangsu) Pilot Free Trade Zone Suzhou AreaSuzhou, Jiangsu 215127), ELPISCIENCE BIOPHARMA, LTD. (1st and 2nd Floor, Bldg. 3, 998 Halei Rd., (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 201203) filed a patent application (PCT/CN2025/102862) for "ANTI-NKG2A ANTIBODIES, FUSION PROTEINS AND USES THEREOF" on Jun 23, 2025. With publication no. WO/2026/001907, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World In...